Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer

Fig. 1

Overall percentage agreement (TCs) between board-certified pathologists’ scoring for NSCLC using (a) the VENTANA PD-L1 (SP263) assay (n = 59) and (b) the Dako PD-L1 IHC PharmDx 22C3 assay (n = 15), NSCLC, non-small cell lung cancer; OPA, overall percentage agreement; TC, tumour cell. Red lines represent standard deviation. Assays were carried out according to manufacturers’ recommended protocols

Back to article page